Literature DB >> 15348370

Effect of water soluble extract of nacre (Pinctada maxima) on alkaline phosphatase activity and Bcl-2 expression in primary cultured osteoblasts from neonatal rat calvaria.

F Moutahir-Belqasmi1, N Balmain, M Lieberrher, S Borzeix, S Berland, M Barthelemy, J Peduzzi, C Milet, E Lopez.   

Abstract

The nacre (mother of pearl) layer of the oyster Pinctada maxima shell can initiate bone formation by human osteoblasts in vivo and in vitro and is a new biomaterial that induces osteogenesis. This activity of nacre could be due to its water-soluble matrix. We examined the action of a water-soluble extract of nacre on the osteoblast phenotype of cells isolated from rat neonatal calvaria by measuring alkaline phosphatase (ALP) activity and by localization of the anti-apoptotic protein Bcl-2 by immunocytochemistry. ALP activity was increased 7% (p<0.001) by 100 microg proteins/ml extract and 20% (p<0.001) by 50 microg proteins/ml extract, but a low concentration of extract decreased the ALP activity by 8%. Cells treated with a high aspartic acid content fraction of the extract had increased ALP activity (23%, p<0.0001). Nacre extract and the fraction have no effect on the proliferation of mature osteoblasts. Immunoreactive Bcl-2 was overproduced in the cytoplasm and nuclei of osteoblasts at all stages of culture. Bcl-2 was found over the whole chromatin in quiescent and mitotic cells at the end of mitosis in the two nuclei in one cell, before cytodieresis. Bcl-2 was also found over chromosomes. Thus, nacre extract stimulates Bcl-2 production in osteoblasts, that is correlated with the cell cycle. Bcl-2 was also abundant in the nucleoli of extract-treated cells. Thus, the concentration and subcellular distribution of Bcl-2 in osteoblasts in primary cultures is influenced by nacre extract, and related to the cell cycle and the regulation of gene expression. Hence, knowledge of how water-soluble extracts of Pinctada maxima nacre act on osteoblasts in vitro may reveal the mechanisms involved in its action in vivo on bone cells and bone regeneration. Copyright 2001 Kluwer Academic Publishers

Entities:  

Year:  2001        PMID: 15348370     DOI: 10.1023/a:1026759431595

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  29 in total

1.  Soluble protein of the organic matrix of mollusk shells: a potential template for shell formation.

Authors:  S Weiner; L Hood
Journal:  Science       Date:  1975-12-05       Impact factor: 47.728

Review 2.  Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation.

Authors:  G S Stein; J B Lian; T A Owen
Journal:  FASEB J       Date:  1990-10       Impact factor: 5.191

3.  Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix.

Authors:  T A Owen; M Aronow; V Shalhoub; L M Barone; L Wilming; M S Tassinari; M B Kennedy; S Pockwinse; J B Lian; G S Stein
Journal:  J Cell Physiol       Date:  1990-06       Impact factor: 6.384

4.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis.

Authors:  D M Hockenbery; Z N Oltvai; X M Yin; C L Milliman; S J Korsmeyer
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

5.  A marriage of bone and nacre.

Authors:  P Westbroek; F Marin
Journal:  Nature       Date:  1998-04-30       Impact factor: 49.962

6.  Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations.

Authors:  C G Bellows; J E Aubin; J N Heersche; M E Antosz
Journal:  Calcif Tissue Int       Date:  1986-03       Impact factor: 4.333

Review 7.  BCL-2, a novel regulator of apoptosis.

Authors:  J R Park; D M Hockenbery
Journal:  J Cell Biochem       Date:  1996-01       Impact factor: 4.429

8.  Responses of bone to titania-hydroxyapatite composite and nacreous implants: a preliminary comparison by in situ hybridization.

Authors:  H Liao; C Brandsten; C Lundmark; T Wurtz; J Li
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

9.  Nacre initiates biomineralization by human osteoblasts maintained in vitro.

Authors:  C Silve; E Lopez; B Vidal; D C Smith; S Camprasse; G Camprasse; G Couly
Journal:  Calcif Tissue Int       Date:  1992-11       Impact factor: 4.333

10.  Bcl-2 blocks apoptotic signal of transforming growth factor-beta in human hepatoma cells.

Authors:  Y L Huang; C K Chou
Journal:  J Biomed Sci       Date:  1998       Impact factor: 8.410

View more
  5 in total

1.  A new method to extract matrix proteins directly from the secretion of the mollusk mantle and the role of these proteins in shell biomineralization.

Authors:  Xiaojun Liu; Chang Liu; Lei Chen; Juan Sun; Yujuan Zhou; Qi Li; Guilan Zheng; Guiyou Zhang; Hongzhong Wang; Liping Xie; Rongqing Zhang
Journal:  Mar Biotechnol (NY)       Date:  2011-01-29       Impact factor: 3.619

2.  A novel matrix protein p10 from the nacre of pearl oyster (Pinctada fucata) and its effects on both CaCO3 crystal formation and mineralogenic cells.

Authors:  Cen Zhang; Shuo Li; Zhuojun Ma; Liping Xie; Rongqing Zhang
Journal:  Mar Biotechnol (NY)       Date:  2006-09-18       Impact factor: 3.619

3.  Zona localization of shell matrix proteins in mantle of Haliotis tuberculata (Mollusca, Gastropoda).

Authors:  Cécile Jolly; Sophie Berland; Christian Milet; Sandrine Borzeix; Evelyne Lopez; Dominique Doumenc
Journal:  Mar Biotechnol (NY)       Date:  2004 Nov-Dec       Impact factor: 3.619

Review 4.  Matrix proteins in the outer shells of molluscs.

Authors:  Cen Zhang; Rongqing Zhang
Journal:  Mar Biotechnol (NY)       Date:  2006-04-18       Impact factor: 3.619

5.  Osteogenic potential of punica granatum through matrix mineralization, cell cycle progression and runx2 gene expression in primary rat osteoblasts.

Authors:  Sahabjada Siddiqui; Mohammad Arshad
Journal:  Daru       Date:  2014-11-20       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.